Search Results - "Canis, F."

Evaluation of the performances of the iQ(®)200 ELITE automated urine microscopy analyser and comparison with manual microscopy method by Dewulf, G, Harrois, D, Mazars, E, Cattoen, C, Canis, F

“…Microscopy urinalysis is one of the last manual analyses in laboratories and it is difficult to control. The automation of this analysis permits our laboratory…”
Get full text

Évaluation des performances de l’automate de cytologie urinaire Iris iQ ®200 ELITE et comparaison avec la méthode manuelle microscopique by Dewulf, G., Harrois, D., Mazars, E., Cattoen, C., Canis, F.

“…L’analyse cytologique des urines réalisée par une méthode manuelle microscopique est difficile à maîtriser. L’automatisation de la cytologie urinaire permet de…”
Get full text

Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients by CANIS, F, HUSSON, M. O, TURCK, D, VIC, P, LAUNAY, V, ATEGBO, S, VINCENT, A, COURCOL, R. J

“…A single daily dose of amikacin 35 mg/kg by i.v. infusion over 30 min in 18 cystic fibrosis patients achieved mean serum peak and trough concentrations of…”
Get full text

Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: a prospective nationwide study in 2011-12 by Robert, Jérôme, Pantel, Alix, Mérens, Audrey, Lavigne, Jean-Philippe, Nicolas-Chanoine, Marie-Hélène

“…To determine proportions and incidence rates of Enterobacteriaceae producing carbapenemase among those non-susceptible (NS) to carbapenems in France. From…”
Get full text

Is the bacterial vaginosis risk factor of prematurity? Study of a cohort of 1336 patients in the hospital of Arras by Bothuyne-Queste, E, Hannebicque-Montaigne, K, Canis, F, Noulard, M-N, Plennevaux, J-L, Tilloy, E, Subtil, D

“…Among risk factors of prematurity, bacterial vaginosis (BV) could play an important role, but few studies took place in our country. In a French population of…”
Get more information

Bactériémie à Gardnerella vaginalis chez un homme by Alidjinou, E.K., Bonnet, I., Canis, F., Dewulf, G., Mazars, E., Cattoen, C.

Get full text

Gardnerella vaginalis bacteremia in a male patient by Alidjinou, E K, Bonnet, I, Canis, F, Dewulf, G, Mazars, E, Cattoen, C

Get full text

Development of an algorithm for phenotypic screening of carbapenemase-producing Enterobacteriaceae in the routine laboratory by Robert, Jérôme, Pantel, Alix, Merens, Audrey, Meiller, Elodie, Lavigne, Jean-Philippe, Nicolas-Chanoine, Marie-Hélène

“…Carbapenemase-producing Enterobacteriaceae (CPE) are difficult to identify among carbapenem non-susceptible Enterobacteriaceae (NSE). We designed phenotypic…”
Get full text

Significance of circulating plasma cells in multiple myeloma by Zandecki, M, Facon, T, Preudhomme, C, Canis, F, Izydorczyk, V, Lovi, V, Hammad, M, Bauters, F, Cosson, A

“…The number of circulating plasma cells (CPC) was determined on mononuclear cell preparations after Giemsa (morphology) and light chain staining…”
Get more information

La vaginose bactérienne est-elle facteur de risque de prématurité ? Étude d’une cohorte de 1336 patientes au centre hospitalier d’Arras by Bothuyne-Queste, É., Hannebicque-Montaigne, K., Canis, F., Noulard, M.-N., Plennevaux, J.-L., Tilloy, E., Subtil, D.

“…La vaginose bactérienne est suspectée d’être un facteur de risque de prématurité, mais peu d’études ont été consacrées à cette association dans notre pays…”
Get full text

Calculus attachment. Review of the literature and new findings by Canis, M F, Kramer, G M, Pameijer, C M

“…This study was undertaken in order to provide current information relative to the modes of calculus attachment to tooth surfaces. A total of 63 freshly…”
Get more information

Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints by Farfour, E., Degand, N., Riverain, E., Fihman, V., Le Brun, C., Péan de Ponfilly, G., Muggeo, A., Jousset, A., Piau, C., Lesprit, P., Chatelain, N., Dortet, L., Poisson, A., Guillard, T., Limelette, A., Mizrahi, A., Le Monnier, A., Fournier, D., Potron, A., Morand, P., Janvier, F., Otto, M.-P., Woerther, P.-L., Decousser, J.-W., Corvec, S., Plouzeau-Jayle, C., Broutin, L., Yin, N., Héry-Arnaud, G., Beauruelle, C., Grillon, A., Lecuru, M., Bille, E., Godreuil, S., Jean Pierre, H., Amara, M., Henry, A., Zahar, J.-R., Carbonelle, E., Jaureguy, F., Lomont, A., Isnard, C., Cattoir, V., Canis, F., Diedrich, T., Flevin, E., Merens, A., Jacquier, H., Gyde, E.

Get full text

Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints by Farfour, E., Degand, N., Riverain, E., Fihman, V., Le Brun, C., Péan de Ponfilly, G., Muggeo, A., Jousset, A., Piau, C., Lesprit, P., Chatelain, N., Dortet, L., Poisson, A., Guillard, T., Limelette, A., Mizrahi, A., Le Monnier, A., Fournier, D., Potron, A., Morand, P., Janvier, F., Otto, M.-P., Woerther, P.-L., Decousser, J.-W., Corvec, S., Plouzeau-Jayle, C., Broutin, L., Yin, N., Héry-Arnaud, G., Beauruelle, C., Grillon, A., Lecuru, M., Bille, E., Godreuil, S., Jean Pierre, H., Amara, M., Henry, A., Zahar, J.-R., Carbonelle, E., Jaureguy, F., Lomont, A., Isnard, C., Cattoir, V., Canis, F., Diedrich, T., Flevin, E., Merens, A., Jacquier, H., Gyde, E.

“…The fosfomycin breakpoint using the disc diffusion method (DDM) changed in the 2019 CA-SFM/EUCAST guidelines v2 (24mm versus 19mm). We assessed its impact on…”
Get full text

Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints by Farfour, E., Degand, N., Riverain, E., Fihman, V., Le Brun, C., Péan de Ponfilly, G., Muggeo, A., Jousset, A., Piau, C., Lesprit, P., Chatelain, N., Dortet, L., Poisson, A., Guillard, T., Limelette, A., Mizrahi, A., Le Monnier, A., Fournier, D., Potron, A., Morand, P., Janvier, F., Otto, M.-P., Woerther, P.-L., Decousser, J.-W., Corvec, S., Plouzeau-Jayle, C., Broutin, L., Yin, N., Héry-Arnaud, G., Beauruelle, C., Grillon, A., Lecuru, M., Bille, E., Godreuil, S., Jean Pierre, H., Amara, M., Henry, A., Zahar, J.-R., Carbonelle, E., Jaureguy, F., Lomont, A., Isnard, C., Cattoir, V., Canis, F., Diedrich, T., Flevin, E., Merens, A., Jacquier, H., Gyde, E.

“…•Fosfomycin is a mainstay for the treatment of community-acquired urinary tract infection (CA-UTI).•The fosfomycin breakpoint for Enterobacterales has changed…”
Get full text

The role of calculus attachment in the treatment of periodontal disease by Canis, M F

Get more information

INF-05 - Le pied diabétique, une prise en charge multidisciplinaire by Joly, A., Di Stefano, S., Vrécourt, A., Angelescu, A., Ben Halima, F., Amiot, S., Canis, F., Dorey, F., Chopin, M.

Get full text

Evaluation of bactericidal activity of cefpirome-aminoglycoside combination against Pseudomonas aeruginosa strains with intermediate sensitivity to cefpirome and in various phenotypes of beta-lactam resistance by Canis, F, Cavallo, J D, Husson, M O

“…The bactericidal activity of cefpirome (CPO)-aminoglycoside (AG) combination was assessed by a kinetic time-kill method against 8 strains of Pseudomonas…”
Get more information

Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis by Canis, F, Trivier, D, Vic, P, Ategbo, S, Turck, D, Husson, M O

“…An aminoglycoside in association with beta-lactam antibiotic are usually the most efficient treatment for Pseudomonas aeruginosa infections in cystic fibrosis…”
Get more information

New barnacle records from the Upper Cretaceous of Alabama by Canis, Wayne F., Zullo, Victor A.

“…Collins (1973), in a major systematic study of the Upper Cretaceous cirripeds of the eastern Gulf Coast, described four species of Cretiscalpellum, four of…”
Get full text

Bacteriological monitoring of the treatment of Pseudomonas aeruginosa infections with amikacin administrated at once-daily dosis in patients with cystic fibrosis by Canis, F, Husson, M O, Vic, P, Ategbo, S, Turck, D, Courcol, R, Leclerc, H

“…The interest of the treatment with a single daily dose of amikacin (AMK) in cystic fibrosis (CF) patients with P. aeruginosa infections has been much debated…”
Get more information